Dual GIP and GLP-1 receptor agonist for incretin-pathway research.
Tirzepatide is a synthetic dual-agonist peptide engineered to bind both GIP and GLP-1 receptors, widely investigated in laboratory studies of energy balance and metabolic signalling. Supplied lyophilized for reconstitution under controlled lab conditions. HPLC-verified purity, sealed vials, dispatched same-day from Melbourne. Research and laboratory use only.
For research and laboratory use only · Not for human or animal consumption